Remove Clinical Development Remove Clinical Research Remove Science
article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

Conclusion As science advances, medical and regulatory frameworks continue to adjust and evolve to accommodate new tools and methods. As biomarkers become increasingly relevant in indicating the workings and effects of novel therapies, their potential as valuable clinical and regulatory endpoints is also gaining recognition.

article thumbnail

Managing Opportunities and Risks in Generative AI Use for Clinical Research

PPD

Generative artificial intelligence (AI) has captured global attention for its transformative potential across industries, and nowhere is the promise greater — or more fraught — than in health care and clinical research. Accelerate your clinical research with our drug development digital solutions from Thermo Fisher Scientific.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The AI model that is changing clinical trial design

Drug Target Review

Chief Executive Officer Steve Herne has spent more than 25 years in clinical research, with senior roles at WCG, Bioclinica and Covance. Unlearn’s digital twins are now in use in both early and late-stage clinical trials, with adoption continuing to grow. Unlearn is one of the few companies applying this approach at scale.

article thumbnail

Leveraging AI Solutions for Clinical Trial Efficiencies

PPD

About us The PPD clinical research business of Thermo Fisher Scientific , the world leader in serving science, enables our customers to accelerate innovation and increase drug development productivity. Ready to learn more about how to leverage AI and machine learning to maximize your clinical trial efficiency?

article thumbnail

Navigating Clinical Development Challenges to Advance Idiopathic Pulmonary Fibrosis Treatments

PPD

Prioritizing the idiopathic pulmonary fibrosis patient experience in clinical trials Understanding the patient experience is paramount to the success of idiopathic pulmonary fibrosis clinical development. Even attending their regular clinic visits can be exhausting and stressful. Ready to connect?

article thumbnail

POLB 001: tackling cytokine storms before they start

Drug Target Review

It takes a family to develop a drug Trembles role at Poolbeg is multifaceted, reflecting the collaborative ethos of the companys scientific team. I take responsibility for identifying pre-clinical research that can support our clinical programs, as well as designing and overseeing its execution, he explains.

article thumbnail

Building the requisite clinical development infrastructure for medical innovation to thrive

Drug Target Review

In an era where science and technology are surpassing what was ever thought possible, the need for the biotech industry to adapt, respond and evolve as quickly and cost efficiently as possible is more urgent than ever. 1 These numbers explain why so many promising biotech firms close their doors each year.